Marcaine (bupivacaine recalls
The FDA has published 5 recalls involving Marcaine (bupivacaine since 2014. The latest was reported on 19 Oct 2016. Most were for particulate matter. Hospira has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls5since 2014
Last 12 months0reported
Class I360% of total
Ongoing0latest 19 Oct 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 3 60%Class II 2 40%Class III 0 0%
Why marcaine (bupivacaine is recalled
Companies
By year
All marcaine (bupivacaine recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg recalled | Hospira Inc. A Pfizer | Foreign Material | Nationwide |
| Drug | CLASS II | Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg recalled | Hospira Inc. A Pfizer | Foreign Material | Nationwide |
| Drug | CLASS I | Marcaine (bupivacaine HCl) injection recalled by Hospira | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS I | Marcaine (bupivacaine HCl) injection recalled by Hospira | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS I | Marcaine (bupivacaine HCl) injection recalled by Hospira | Hospira | Particulate Matter | Nationwide |
Should you stop taking Marcaine (bupivacaine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.